Bayer’s Consumer Health Sales Stay Cool During Summer Months

Bayer reported consumer health sales globally fell 1.4% to $1.64bn after a late start to the allergy season drove down Claritin sales. Aleve analgesics sales grew 3.3% to $112.5m on US line extensions while Alka Seltzer line sales were flat at $47.5m.

Bayer AG’s consumer health sales stumbled again in the company's latest quarter as a late start to the US allergy season slowed sales of the Claritin line and supply disruptions affected Bayer Aspirin revenues.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Marketing & Advertising

More from Compliance